(UroToday.com) Petros Grivas (Seattle Cancer Care Alliance) chaired the first session of the 7th Annual Leo and Anne Albert Institute for Bladder Cancer Care and Research (AIBCCR) Symposium on immuno-oncology, setting the scene for the role of immunotherapy (IO) in urothelial cancer (UC) by summarizing recent advances and outlining unanswered questions.